Neisseria gonorrhoeae vaccines: a contemporary overview
Clinical Microbiology Reviews · 14.03.2024 · 37 (1)
DOI: 10.1128/cmr.00094-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 14.03.2024. Verfasst von Eloise Williams und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Austra…. Hauptthemen laut MEDLINE: Gonorrhea, Anti-Infective Agents, Vaccines. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Future Fund, DHAC | National Health and Medical Research Council (NHMRC), National Health and Medical Research Council.
Abstract (Originalsprache)
Neisseria gonorrhoeae infection is an important public health issue, with an annual global incidence of 87 million. N. gonorrhoeae infection causes significant morbidity and can have serious long-term impacts on reproductive and neonatal health and may rarely cause life-threatening disease. Global rates of N. gonorrhoeae infection have increased over the past 20 years. Importantly, rates of antimicrobial resistance to key antimicrobials also continue to increase, with the United States Centers for Disease Control and Prevention identifying drug-resistant N. gonorrhoeae as an urgent threat to public health. This review summarizes the current evidence for N. gonorrhoeae vaccines, including historical clinical trials, key N. gonorrhoeae vaccine preclinical studies, and studies of the impact of Neisseria meningitidis vaccines on N. gonorrhoeae infection. A comprehensive survey of potential vaccine antigens, including those identified through traditional vaccine immunogenicity approaches, as well as those identified using more contemporary reverse vaccinology approaches, are also described. Finally, the potential epidemiological impacts of a N. gonorrhoeae vaccine and research priorities for further vaccine development are described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Eloise Williams, Kate L Seib, James S McCarthy, Deborah A Williamson
Förderung
- Medical Research Future Fund
- DHAC | National Health and Medical Research Council (NHMRC)
- National Health and Medical Research Council
Zitieren
APA
Williams, E., Seib, K. L., Fairley, C. K., Pollock, G. L., Hocking, J. S., McCarthy, J. S., & Williamson, D. A. (2024). Neisseria gonorrhoeae vaccines: a contemporary overview. Clinical Microbiology Reviews, 37(1). https://doi.org/10.1128/cmr.00094-23
Vancouver
Williams E, Seib KL, Fairley CK, Pollock GL, Hocking JS, McCarthy JS, et al. Neisseria gonorrhoeae vaccines: a contemporary overview. Clinical Microbiology Reviews. 2024;37(1). doi:10.1128/cmr.00094-23
BibTeX
@article{Williams2024,
author = {Williams, Eloise and Seib, Kate L and Fairley, Christopher K and Pollock, Georgina L and Hocking, Jane S and McCarthy, James S and Williamson, Deborah A},
title = {Neisseria gonorrhoeae vaccines: a contemporary overview},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {1},
doi = {10.1128/cmr.00094-23}
}
EUVIMED